SCHEMBL13664169

SCHEMBL13664169

Cc1ccc(C(=O)c2nn(-c3ccccc3Cl)c(N)c2C#N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
MAPT P10636 4/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
KDM4E B2RXH2 4/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
POLB P06746 3/20 0.40
RIPK1 Q13546 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
TSHR P16473 1/20 0.38
CNR1 P21554 2/20 0.38
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13664195 0.87 KDM4E (0.50) ALDH1A1MAPTLMNAKDM4EMEN1
SCHEMBL13664164 0.86 MAPK14 (0.49) ALDH1A1MAPTHPGDLMNAKDM4E
SCHEMBL13667959 0.85 DRD2 (0.40) ALDH1A1MAPTLMNAPOLBRIPK1
SCHEMBL13664172 0.84 MAPT (0.64) ALDH1A1MAPTHPGDLMNAKDM4E
SCHEMBL13664173 0.82 MAPT (0.55) ALDH1A1MAPTHPGDLMNAKDM4E
SCHEMBL13664161 0.82 MAPT (0.51) ALDH1A1MAPTHPGDLMNAKDM4E
SCHEMBL13664167 0.81 MAPT (0.50) ALDH1A1MAPTHPGDLMNAKDM4E
SCHEMBL13664184 0.81 CNR1 (0.40) ALDH1A1MAPTHPGDLMNAKDM4E
SCHEMBL13664200 0.81 MAPT (0.42) ALDH1A1MAPTHPGDLMNAKDM4E
SCHEMBL13664187 0.81 MAPT (0.40) ALDH1A1MAPTHPGDLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists GIPR, GPR119, GLP1R ALDH1A1 3415/4885MAPT 4701/4885HPGD 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.